Bulk Pharmaceutical API Sources for dobutamine hydrochloride

Bulk Pharmaceutical API Sources for dobutamine hydrochloride

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		D0676_SIGMA
NovoSeek		65324
MP Biomedicals		159780
ISpharm		I14-2722

Bulk Active Pharmaceutical Ingredient (API) Sources for Dobutamine Hydrochloride

Last updated: February 20, 2026

Dobutamine hydrochloride is a synthetic catecholamine used primarily as an inotropic agent in cardiac failure and shock. Its bulk API sourcing involves multiple manufacturers globally, with suppliers categorized into large-scale chemical producers, contract manufacturing organizations (CMOs), and regional API suppliers. The supply chain is influenced by regulatory standards, manufacturing capacity, and geographic distribution.

Major API Suppliers for Dobutamine Hydrochloride

Supplier Name	Location	Certification & Regulatory Approvals	Estimated Capacity	Notes
Zhejiang Hisun Pharmaceutical Co.	China	GMP, WHO GMP	10+ metric tons/year	One of the largest Chinese API manufacturers with export licenses.
Zhejiang Promotions Biotechnology	China	GMP, ISO 9001	5+ metric tons/year	Known for bulk API production; supplies multiple pharma companies.
FAMAE (Laboratorios Famae)	Chile	GMP	2+ metric tons/year	Regional Latin American supplier, compliant with local standards.
PCAS (Produits Chimiques Specialises)	France	EU GMP	1-3 metric tons/year	European supplier with high regulatory compliance.
Meryer (Shenzhen) Chemical Co.	China	GMP	5+ metric tons/year	Diversified chemical supplier that produces APIs, including dobutamine hydrochloride.
Bachem AG	Switzerland	GMP, ISO, FDA approval	1+ metric tons/year	Known for high purity APIs and custom synthesis.
Thermo Fisher Scientific (via CMOs)	USA, Global Partners	GMP, FDA, EMA	Varies	Supplies APIs through partnerships with contract manufacturers.

Source Overview:

• The Chinese market dominates dobutamine hydrochloride manufacturing, with Zhejiang Hisun and Shenzhen Meryer as prominent producers, benefiting from low production costs and large capacity (1-10 metric tons annually).
• European suppliers like PCAS comply with stricter EU GMP standards, sometimes resulting in higher prices but enhanced quality assurance.
• North American and Swiss suppliers like Bachem and Thermo Fisher focus on high-purity APIs, often serving niche markets requiring stringent quality standards.

Key Considerations in API Sourcing

• Regulatory Compliance: Suppliers must adhere to cGMP standards, typically verified through audits and certification (e.g., WHO GMP, EU GMP, FDA approval).
• Capacity and Lead Time: Large capacity suppliers can fulfill high-volume orders with shorter lead times. Small or specialized suppliers may have longer delivery periods due to capacity constraints or quality control steps.
• Pricing Dynamics: Chinese suppliers offer competitive pricing, but import tariffs, quality assurance, and regulatory acceptance influence total costs.
• Supply Chain Security: Diversification across regions mitigates risks associated with geopolitical issues, trade restrictions, or manufacturing disruptions.

Contract Manufacturing and Custom Synthesis

Many pharmaceutical companies procure dobutamine hydrochloride API through CMOs to meet regulatory and quality standards. Major CMOs globally include Lonza, Recipharm, and Catalent, capable of scale production from 1 to 10+ metric tons annually, often with dedicated facilities ensuring compliance with client specifications and regulatory requirements.

Regulatory Status & Market Trends

• The API is approved for pharmaceutical use in major markets (US, EU, China).
• Market growth driven by increasing demand for cardiac drugs in aging populations.
• Supply chain shifts include increased inspections and audits post-2020 due to global supply chain disruptions.

Summary

Attribute	Summary
Leading Regions	China (largest), Europe, North America
Major Suppliers	Zhejiang Hisun, Shenzhen Meryer, PCAS, Bachem
Production Capacity	1-10+ metric tons per year
Quality Certifications	GMP, WHO GMP, EU GMP, FDA included
Price Range	Low (China) to moderate/high (Europe/US)

Key Takeaways

• China dominates API production, offering the largest capacity at competitive prices.
• European suppliers focus on high-quality standards, with certifications such as EU GMP.
• Supply chain diversification enhances security amid geopolitical and logistical risks.
• Contract manufacturing organizations facilitate scaling and regulatory compliance.
• Monitoring regulatory updates and market dynamics is essential for procurement planning.

FAQs

Q1: What are the primary regions for dobutamine hydrochloride API production?
A1: China leads in production capacity, followed by Europe and North America.

Q2: How do regulatory standards impact supplier selection?
A2: Suppliers with GMP, WHO GMP, or FDA approval ensure compliance; strict standards typically command higher prices.

Q3: What factors determine API pricing?
A3: Production volume, raw material costs, regulatory compliance, and geopolitical factors.

Q4: Are there regional supply chain risks for dobutamine API?
A4: Yes; reliance on Chinese suppliers may pose risks amid trade restrictions, whereas European and US suppliers offer diversified sources.

Q5: How can companies manage API sourcing safety?
A5: Use multiple suppliers, verify certifications, conduct audits, and maintain regulatory compliance documentation.

---

References

[1] U.S. Food and Drug Administration. (2022). Guide to Pharmaceutical Good Manufacturing Practices (GMP).
[2] European Medicines Agency. (2022). GMP guidelines for active substances.
[3] Zhejiang Hisun Pharmaceutical Co. (2023). Annual Report.
[4] Bachem AG. (2023). Product Portfolio & Certifications.
[5] MarketWatch. (2022). Global API Market Trends.